Lanadelumab Injection Treatment For The Prevention Of Hereditary Angioedema (HAE): Design, Development And Place In Therapy

Despite the efficacy of the on-demand treatment for the control of acute attacks of Hereditary Angioedema due to C1-Inhibitor Deficiency (C1-INH-HAE), the number and severity of attacks and the impairment in the quality of life of the affected patients have led to the development of a new monoclonal...

Descripción completa

Detalles Bibliográficos
Autores principales: Bova, Maria, Valerieva, Anna, Wu, Maddalena Alessandra, Senter, Riccardo, Perego, Francesca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815761/
https://www.ncbi.nlm.nih.gov/pubmed/31695331
http://dx.doi.org/10.2147/DDDT.S192475

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815761/
https://www.ncbi.nlm.nih.gov/pubmed/31695331
http://dx.doi.org/10.2147/DDDT.S192475

Ejemplares similares